Antiretroviral prophylaxis for HIV infection in injecting drug users in Bangkok, Thailand (the Bangkok Tenofovir Study): a randomised, double-blind, placebo-controlled phase 3 trial
Top Cited Papers
- 1 June 2013
- journal article
- research article
- Published by Elsevier BV in The Lancet
- Vol. 381 (9883), 2083-2090
- https://doi.org/10.1016/s0140-6736(13)61127-7
Abstract
No abstract availableKeywords
This publication has 25 references indexed in Scilit:
- MTN-001: Randomized Pharmacokinetic Cross-Over Study Comparing Tenofovir Vaginal Gel and Oral Tablets in Vaginal Tissue and Other CompartmentsPLOS ONE, 2013
- Preexposure Prophylaxis for HIV Infection among African WomenThe New England Journal of Medicine, 2012
- Enrollment Characteristics and Risk Behaviors of Injection Drug Users Participating in the Bangkok Tenofovir Study, ThailandPLOS ONE, 2011
- Preexposure Chemoprophylaxis for HIV Prevention in Men Who Have Sex with MenThe New England Journal of Medicine, 2010
- Sensitivity of Five Rapid HIV Tests on Oral Fluid or Finger-Stick Whole Blood: A Real-Time Comparison in a Healthcare SettingPLOS ONE, 2010
- Prevention of Rectal SHIV Transmission in Macaques by Daily or Intermittent Prophylaxis with Emtricitabine and TenofovirPLoS Medicine, 2008
- Randomized, Double‐Blind, Placebo‐Controlled Efficacy Trial of a Bivalent Recombinant Glycoprotein 120 HIV‐1 Vaccine among Injection Drug Users in Bangkok, ThailandThe Journal of Infectious Diseases, 2006
- Continued high HIV-1 incidence in a vaccine trial preparatory cohort of injection drug users in Bangkok, ThailandAIDS, 2001
- A Case–Control Study of HIV Seroconversion in Health Care Workers after Percutaneous ExposureThe New England Journal of Medicine, 1997
- Validating population surveys for the measurement of HIV/STD prevention indicatorsAIDS, 1995